Process Service

37 years of expertise in fine chemical and pharmaceutical industry

Fine chemical plants

High purity products

Bulk APIs Productions

Sterile production lines (bulk, filling and lyophilizations)

Biopharmaceutical plants (fermentations, DSP, mAbs)

High Potent APIs (HP API) Productions

Utilities and clean utilities systems design

HIGH POTENT APIs (HP API) PRODUCTIONS

Faravelli obtained the renewal of ISO 9001

On 5 June 2023 Giusto Faravelli Spa obtained the renewal of UNI EN ISO 9001:2015 certification. The audit was carried out by the certifying body CSQA, which confirmed compliance with the requirements. Our company operates within the framework of an Integrated Quality Management System to maintain a high and constantly increasing level of products and services, aiming at compliance with international quality standards and close to the needs of the market and current regulations.

The renewal of the ISO 9001 certification not only makes us proud, but also confirms the company’s commitment and focus on quality. ISO 9001, the best-known and most widespread standard for quality management systems, is a tool that supports companies in achieving their objectives by making the best use of available resources.

ISO 9011 accompanies companies on a path of continuous management improvement in terms of efficiency, cost reduction, customer satisfaction and loyalty.

HQ of the Group, Giusto Faravelli Spa has been ISO 9001 certified since 1993.

CSQA has been accompanying the company’s certification process since 2016.

OQEMA and Lanxess have entered into a new partnership

OQEMA and Lanxess have entered into a new pan-European partnership for the distribution of Lanxess’ Colorant Additives. The portfolio offers customers all over the world a broad selection of high-quality colorants under the brand names Bayfast®, Bayplast®, Bayscript®, Levanox®, Levanyl®, Levascreen® and Macrolex®. André Schommer, Group Segment Manager Case at OQEMA, says: “We are very excited to begin our new partnership with Lanxess to further strengthen our specialty chemicals portfolio. Our European sales and tech- nical teams, who have a deep understanding of the market, and our wide range of services will enable us to enhance the growth of Lanxess’ colorant additives business.” “This new relationship can only strengthen and enhance Lanxess’ position in the market place while continuing to deliver a first-class customer experience. We look forward to the growth and success that this partnership will bring”, Carl Waite, Lanxess Head of Sales Polymer Additives North/ East Europe, commented.

Innovative solutions were explored at Pharmap 2023

Presenting innovative solutions and contributing to further development of ongoing pharmaceutical trends were the main directions of Pharmaceutical Manufacturing and Packaging Congress. Pharmap 2023 gathered pharmaceutical companies, CMOs and CDMOs, governmental bodies to exchange experience in digital transformation and discuss innovative solutions and business practices. The Congress was held on June, 12-13, in Geneva, Switzerland. The first day of the Congress started with the executive opening panel, where speakers from LabWare, Optel Group, 3V Tech, GSK, PharmaLedger Association, Bushu Pharmaceuticals, Pharmazac had a discussion about new models for pharma manufacturing and packaging. Fausto Artico, Global R&D Tech Head and Director of Innovation and Data Science at GSK, shared his thoughts on how companies can innovate and introduce changes in manufacturing. Also, the speaker pointed out what com- panies need to do to make it work not only from the tech point of view but also in terms of the leadership style with the aim to create a strategic vision for the people. The agenda of that day included the session dedicated to up-to-date topics of the pharmaceutical industry, including the sustainable future of the pharmaceutical packaging model, supply chain optimization, cost-optimization, agile pharma manufacturing, and innovative packaging solutions. One of the highlights of the second day of the Congress was the session dedicated to MES & robotics implementation driving towards Industry 4.0. Speakers shared their thoughts on MES implementation, paperless manufacturing, digital manufacturing and operational challenges, as well as transformation of pharmaceuticals with robotic solutions and AI. Speaking about robotics implementation, it begins to challenge the traditional approaches, practices, and business models for the manufacture of pharmaceuticals. The application of advanced robotics has the potential to increase the agility, efficiency, flexibility, and quality of the industrial production of medicines. The next edition of the Pharmaceutical Manufacturing and Packaging Congress 2024 is going to take place on 22-23, April, in Amsterdam, the Netherlands.